ERGO EU Project

ERGO aims to improve hazard assessment of endocrine disrupting chemicals (EDCs) for the protection of human health and the environment by breaking down the wall that currently exists between the different research fields that investigate adverse effects of EDCs in different vertebrate classes, from fish and amphibians (non-mammalian vertebrates) to humans (mammalian vertebrates) by demonstrating that it is feasible to extrapolate effects of EDCs across the vertebrate classes, i.e. an adverse effect observed in a fish or amphibian will also raise concern for an adverse effect in humans. This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 825753 (ERGO). This output reflects the views only of the author(s), and the European Commission cannot be held responsible for any use which may be made of the information contained therein.